Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$83.69

1.52 (1.85%)

16:03
02/13/18
02/13
16:03
02/13/18
16:03

Neurocrine sees FY18 operating expenses $365M-$395M

Sees FY18 milestones under the AbbVie agreement $40M contingent on an FDA approval of elagolix for endometriosis. The 2018 anticipated expenses include an estimated $50M of share-based compensation expense. The increase in operating expenses is largely attributable to increased investment in INGREZZA sales and marketing activities coupled with increased R&D efforts for Tourette syndrome, opicapone, new early stage programs, and post-marketing clinical activities.

  • 13

    Feb

  • 14

    Feb

  • 08

    Mar

NBIX Neurocrine
$83.69

1.52 (1.85%)

01/05/18
JEFF
01/05/18
NO CHANGE
Target $105
JEFF
Buy
Neurocrine price target raised to $105 from $81 at Jefferies
Jefferies analyst Biren Amin raised his price target for Neurocrine Biosciences (NBIX) to $105 following his fourth proprietary survey on tardive dyskinesia. The respondents provided bullish estimates compared to past surveys, which sees prescribing possibly doubling from current levels for Neurocrine's Ingrezza and Teva's (TEVA) Austedo in both mod-severe and mild Tardive Dyskinesia by the end of 2018, Amin tells investors in a research note. The analyst expects Ingrezza to lead Austedo in market share raised his revenue estimates for Neurocrine. Amin keeps a Buy rating on the shares.
01/16/18
OPCO
01/16/18
NO CHANGE
Target $95
OPCO
Outperform
Neurocrine price target raised to $95 from $85 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Neurocrine to $95 from $85 based on preliminary Q4 results increasing his revenue and earnings estimates. The analyst reiterates an Outperform rating on the shares.
01/16/18
NEED
01/16/18
NO CHANGE
Target $95
NEED
Buy
Neurocrine price target raised to $95 from $86 at Needham
Needham analyst Alan Carr raised his price target on Neurocrine Biosciences to $95 after the company pre-announced 2017 revenue and INGREZZA sales last week. The analyst says the above-estimate print was in part the result of a delay in the uptake of the 80mg capsule that is less expensive than the 40mg. Carr believes that the launch is proceeding well, warranting an increase in FY18 revenue while raising his 2018-2020 INGREZZA sales forecast to $350M from $340M. The analyst keeps his Buy rating on Neurocrine Biosciences.
01/22/18
OPCO
01/22/18
NO CHANGE
OPCO
Neurocrine, CymaBay could benefit from increased M&A, says Oppenheimer
Oppenheimer analyst Jay Olson notes that driven by tax reform and cash repatriation, Biotech investors expect increased M&A activity. The analyst believes tax reform with cash repatriation will increase firepower of potential buyers, and points out that managements stated interest in targets with strategic fit. In his coverage universe, Olson believes Neurocrine (NBIX), Portola Pharmaceuticals (PTLA) and CymaBay (CBAY) shares could benefit from increased M&A based on their therapeutic areas and strategic fit.

TODAY'S FREE FLY STORIES

CYH

Community Health

$4.46

-0.18 (-3.88%)

15:55
06/21/18
06/21
15:55
06/21/18
15:55
Hot Stocks
Breaking Hot Stocks news story on Community Health »

S&P revises Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

AMZN

Amazon.com

$1,728.40

-21.19 (-1.21%)

15:53
06/21/18
06/21
15:53
06/21/18
15:53
Periodicals
Leak shows Amazon Prime Day to start on July 16, TechRadar says »

Amazon's annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$52.31

-1.15 (-2.15%)

15:50
06/21/18
06/21
15:50
06/21/18
15:50
Options
Intel implied volatility moves higher as shares slide »

Intel implied volatility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

VDMCY

Vodacom

$0.00

(0.00%)

15:49
06/21/18
06/21
15:49
06/21/18
15:49
Conference/Events
Vodacom management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

PCRX

Pacira

$35.40

-4.45 (-11.17%)

, HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

15:42
06/21/18
06/21
15:42
06/21/18
15:42
Recommendations
Pacira, Heron Therapeutics analyst commentary  »

Pacira's Exparel may…

PCRX

Pacira

$35.40

-4.45 (-11.17%)

HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

QQQ

Invesco QQQ Trust

$175.78

-1.47 (-0.83%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Options
Contrarian flow in QQQ 1day calls »

Contrarian flow in QQQ…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSEY

Samsonite International

$0.00

(0.00%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Conference/Events
Samsonite International management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

SENS

Senseonics

$4.93

0.07 (1.44%)

15:37
06/21/18
06/21
15:37
06/21/18
15:37
Hot Stocks
Senseonics up 5% after reopening following FDA approval news »

Senseonics shares are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

WATT

Energous

$16.10

-0.61 (-3.65%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Options
Energous put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LDOS

Leidos

$57.77

-0.57 (-0.98%)

15:29
06/21/18
06/21
15:29
06/21/18
15:29
Recommendations
Leidos analyst commentary  »

Leidos may have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LDOS

Leidos

$57.75

-0.59 (-1.01%)

, HRS

Harris

$143.06

-2.18 (-1.50%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Periodicals
TSA terminates contract with Peraton, Washington Business Journal says »

The Transportation…

LDOS

Leidos

$57.75

-0.59 (-1.01%)

HRS

Harris

$143.06

-2.18 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FOSL

Fossil

$31.65

2.43 (8.32%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Options
Fossil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

, SPX

S&P 500

$0.00

(0.00%)

15:22
06/21/18
06/21
15:22
06/21/18
15:22
Technical Analysis
Technical Take: S&P 500 at important technical juncture into the close »

Last week in a summary…

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.58

0.08 (0.15%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/21/18
06/21
15:16
06/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:15
06/21/18
06/21
15:15
06/21/18
15:15
Hot Stocks
Senseonics says FDA approves PMA to market Eversense CGM System »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

15:15
06/21/18
06/21
15:15
06/21/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SRE

Sempra Energy

$111.85

-0.68 (-0.60%)

15:12
06/21/18
06/21
15:12
06/21/18
15:12
Hot Stocks
CPUC rejects SGE&E, SoCalGas request to build new nat gas pipeline in San Diego »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.28

-0.59 (-0.91%)

15:10
06/21/18
06/21
15:10
06/21/18
15:10
Options
CSX sees increased put activity »

CSX sees increased put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

MFG

Mizuho Financial Group

$3.37

-0.07 (-2.03%)

15:05
06/21/18
06/21
15:05
06/21/18
15:05
Conference/Events
Mizuho Financial Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

HRTX

Heron Therapeutics

$40.10

9.4 (30.62%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

SGH

Smart Global

$40.24

-0.27 (-0.67%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Options
SMART Global options imply 15.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

STMP

Stamps.com

$249.35

-30.95 (-11.04%)

15:02
06/21/18
06/21
15:02
06/21/18
15:02
Recommendations
Stamps.com analyst commentary  »

Any selloff in Stamps.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.